
WASHINGTON — President Biden’s “moonshot” biomedical research agency will be housed within the National Institutes of Health, according to two sources familiar with the decision-making process.
The decision marks the end of a lengthy debate in Washington about whether the new agency, known as ARPA-H, should be independent or exist as a wing of the NIH.
But there’s a twist: Instead of reporting to the NIH director, the new agency’s leader will report directly to the secretary of health and human services.

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.